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Background
Drug hypersensitivity reactions (DHRs) can be classified
into IgE-induced, immediate type and T-cell mediated,
delayed-type reactions. While the former are considered
as Th2-driven immune responses characterized by IL-5-
secretion, the later are regarded as mainly provoked by
IFN-gamma-producing Th1 cells. However, it has been
suggested that delayed-type DHRs could also be elicited
by IL-5 or a mixed T cell cytokine pattern.
Methods
We sought to characterize drug-specific T cell subpopula-
tions in patients with delayed-type DHRs to beta-lactam
antibiotics by enzyme-linked immunospot (ELISPOT)
assay, a sensitive technique to detect antigen-specific cyto-
kine-producing cells. Peripheral blood was drawn from
eight patients who had experienced maculopapular
exanthema as a clinical manifestation of a DHR against
beta-lactam antibiotics (penicillin, amoxicillin or cefur-
oxim), which was confirmed by skin patch-test. The
occurrence and frequencies of drug-specific IL-5-, IFN-
gamma- and IL-10-producing T cells were analyzed by
ELISPOT assay and compared to ten healthy controls
without history of delayed-type DHRs.
Results and conclusion
As expected, ELISPOT analysis of peripheral blood mono-
nuclear cells (PBMC) revealed increases in drug-specific
IFN-gamma-producing T cells. However, in a subgroup of
patients with delayed-type DHRs, augmented numbers of
drug-specific IL-5-secreting T cells were observed, regard-
less which drug was taken. Of note, IL-10 positive T cells
were not decreased in drug-allergic patients when com-
pared with healthy controls. Our results show that DHRs
are characterized by distinct patterns of cytokine-secreting
lymphocytes which resemble either Th1, Th2 or a mixed
type of Th cells. Thus, determining both IFN-gamma- and
IL-5-positive (but not IL-10-producing) cells by ELISPOT
assay increases the sensitivity in detecting drug-specific
T cells. This may help diagnosing drug-allergy in patients
with suspected DHRs negative by other conventional
allergy tests.
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